Nuveen Asset Management, LLC Vaxcyte, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 529,650 shares of PCVX stock, worth $23.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

529,650

Previous 463,937 14.16%

Holding current value

$23.7 Million

Previous $53 Million 18.14%

% of portfolio

0.01%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$80.97 - $117.93 $5.32 Million - $7.75 Million	65,713 Added 14.16%	529,650 $43.4 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $9.79 Million - $16.3 Million	138,776 Added 42.68%	463,937 $53 Million
Q2 2024 Aug 09, 2024	BUY	$60.06 - $78.77 $829,368 - $1.09 Million	13,809 Added 4.44%	325,161 $24.6 Million
Q1 2024 May 13, 2024	BUY	$59.79 - $81.05 $1.82 Million - $2.47 Million	30,496 Added 10.86%	311,352 $21.3 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $705,464 - $986,405	-15,556 Reduced 5.25%	280,856 $17.6 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $115,276 - $133,068	2,506 Added 0.85%	296,412 $15.1 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $1.2 Million - $1.88 Million	34,688 Added 13.38%	293,906 $14.7 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $103,079 - $134,142	2,842 Added 1.11%	259,218 $9.72 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $1.38 Million - $3.21 Million	66,864 Added 35.28%	256,376 $12.3 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $810,186 - $1.07 Million	37,353 Added 24.55%	189,512 $4.55 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $200,367 - $301,231	11,333 Added 8.05%	152,159 $3.31 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $26,504 - $40,014	-1,518 Reduced 1.07%	140,826 $3.48 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $205,506 - $281,348	-10,637 Reduced 6.95%	142,344 $2.99 Million
Q3 2021 Nov 12, 2021	SELL	$20.26 - $26.97 $159,142 - $211,849	-7,855 Reduced 4.88%	152,981 $3.88 Million
Q2 2021 Aug 16, 2021	BUY	$16.45 - $24.06 $1.07 Million - $1.57 Million	65,143 Added 68.07%	160,836 $3.62 Million
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $429,030 - $670,446	22,992 Added 31.63%	95,693 $1.89 Million
Q4 2020 Feb 16, 2021	SELL	$26.57 - $51.74 $131,734 - $256,526	-4,958 Reduced 6.38%	72,701 $1.93 Million
Q3 2020 Nov 16, 2020	BUY	$26.5 - $55.4 $2.06 Million - $4.3 Million	77,659 New	77,659 $3.84 Million

Others Institutions Holding PCVX

# of Institutions

323

Shares Held

139M

Call Options Held

229K

Put Options Held

160K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.65B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Vaxcyte, Inc. Transaction History